SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
30/26/30	€0.0910	-.--%	1,69,049
29/26/29	€0.0910	+4.00%	2,68,589
28/26/28	€0.0875	+1.74%	1,36,471
27/26/27	€0.0860	-.--%	97,178
26/26/26	€0.0860	+0.12%	1,07,781

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 10:25:00 30/10/2026 pm IST			5-day change	1st Jan Change
0.0910 ^EUR	-.--%		+5.94%	-9.90%

08/10	SpineGuard: Revenue Down, but Volumes Up
08/10	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2026	CI

Market Cap	88.16L 98.43L 81.09L 73.47L 1.37Cr 93Cr 1.4Cr 9.67Cr 3.88Cr 49Cr 3.69Cr 3.62Cr 155.05Cr	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	85.5L 95.47L 78.65L 71.26L 1.33Cr 91Cr 1.36Cr 9.38Cr 3.77Cr 48Cr 3.58Cr 3.51Cr 150.38Cr	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.13%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALSGD	Real-time
Deutsche Boerse AG	6W5	Delayed
Börse Stuttgart	6W5	Delayed
Boerse Muenchen	6W5	Real-time

08/10	SpineGuard: Revenue Down, but Volumes Up
08/10	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2026	CI
05/10	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon
10/09	SpineGuard SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09/09	SpineGuard says it can cover its funding needs through the second quarter of 2027
04/09	Weekly earnings calendar: Oracle vs Adobe, a battle of old hands
25/08	SpineGuard Wins US Patent for Robotic Ultrasound Technology	MT
24/08	Spineguard Obtains New U.S. Patent for Innovative Ultrasound Technology Designed to Determine Entry Point and Pedicular Drilling Trajectory	CI
24/08	SpineGuard lands a new US patent in spinal guidance
28/07	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
27/07	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI
27/07	SpineGuard Secures a New Patent in the United States
09/07	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI

SpineGuard Share Price

Stocks

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news: SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Price Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

08/10	SpineGuard Announces Its Q3 Revenue	BU
09/09	SpineGuard Reports 2026 Half-Year Results	BU
24/08	SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory	BU
27/07	SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion	BU
08/07	SpineGuard Announces its H1 2026 Revenue	BU

09/10	Bourse : ça bouge chez Saint-Laurent (Kering) et BNP Paribas, SpaceX s'attaque aux opérateurs mobiles
09/10	OpenAI plombe l'ambiance et le Nasdaq
08/10	SpineGuard : chiffre d'affaires en baisse, mais volumes en hausse
08/10	SpineGuard annonce son chiffre d’affaires du troisième trimestre 2026
07/10	Agenda Zonebourse des résultats de sociétés : le 8 octobre 2026

1 week	+5.94%
1 month	+2.25%
3 months	+9.38%
6 months	-6.09%
Current year	-9.90%

1 week	0.08	0.09
1 month	0.08	0.09
Current year	0.08	0.14
1 year	0.08	0.18
3 years	0.08	0.41
5 years	0.08	1.67
10 years	0.08	5.27

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	15/02/2020
Stéphane Bette CEO	Chief Executive Officer	-	13/07/2017
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	01/01/2009

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	16/01/2009
Maurice Bourlion BRD	Director/Board Member	-	02/07/2009
Pierre Jérôme CHM	Chairman	-	01/03/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	-.--%	+5.94%	-14.95%	-66.30%	98.43L
ABBOTT LABORATORIES	+1.56%	+2.41%	-14.09%	+11.78%	18TCr
MEDTRONIC PLC	-0.59%	+1.18%	+6.44%	+36.26%	12TCr
STRYKER CORPORATION	-6.38%	-4.98%	-18.07%	+7.28%	11TCr
ESSILORLUXOTTICA	+3.42%	+1.71%	-41.92%	+7.51%	9.46TCr
CENCORA, INC.	+0.09%	-0.05%	-2.06%	+76.70%	6.31TCr
HOYA CORPORATION	-4.79%	-4.42%	-0.74%	+63.05%	5.57TCr
BECTON, DICKINSON AND COMPANY	-0.23%	-0.52%	+10.73%	-22.03%	5.39TCr
IDEXX LABORATORIES, INC.	-4.30%	-1.64%	-12.44%	+39.42%	4.34TCr
ALCON INC.	+0.58%	+2.00%	-1.17%	-9.88%	3.47TCr
Average	-1.06%	+0.65%	-8.83%	+14.38%	7.58TCr
Weighted average by Cap.	-0.80%	+0.24%	-10.51%	+21.76%

	2024	2025
Net sales	46.48L 51.9L 42.75L 38.74L 72.41L 49Cr 73.77L 5.1Cr 2.05Cr 26Cr 1.95Cr 1.91Cr 82Cr	37.57L 41.95L 34.56L 31.32L 58.54L 40Cr 59.63L 4.12Cr 1.65Cr 21Cr 1.57Cr 1.54Cr 66Cr
Net income	-30.82L -34.41L -28.35L -25.69L -48.01L -33Cr -48.91L -3.38Cr -1.36Cr -17Cr -1.29Cr -1.26Cr -54Cr	-20.68L -23.09L -19.02L -17.23L -32.21L -22Cr -32.81L -2.27Cr -91.04L -12Cr -86.64L -84.8L -36Cr
Net Debt	18.19L 20.31L 16.73L 15.16L 28.33L 19Cr 28.86L 1.99Cr 80.08L 10Cr 76.21L 74.59L 32Cr	-3L -3L -2L -2L -4L -2.81Cr -4L -29.11L -11.69L -1.48Cr -11.12L -10.88L -4.67Cr